January/February 2010, Vol 3, No 1

Regulatory

Orphan Drug Pricing and Payer Management in the United States: Are We Approaching the Tipping Point?
Rebecca Hyde
; Diana Dobrovolny
Stakeholder Perspective by Kavita V. Nair, PhD

Business

Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care
Alyssa Pozniak, PhD
; Lois Olinger, MA
; Victoria Shier, MA
Stakeholder Perspective by Gary M. Owens, MD

Clinical

Hypertension Management: An Update
Quang Nguyen, DO
; Joann Dominguez, MD
; Loida Nguyen, PharmD
; Nageshwara Gullapalli, MD
Stakeholder Perspective by Lekshmi Dharmarajan, MD, FACP, FACC

Generic Drug Trends

Competition from Biosimilars an Incentive for Innovation
Dalia Buffery, MA, ABD

Industry Trends

Emerging Trends in Breast Cancer Management
Caroline Helwick
Rheumatology Pipeline Boasts Innovation, ID Line Is Drying Up: ACR/IDSA 2009
Alice Goodman
Cardiology Pipeline Is Promising: AHA 2009
Wayne Kuznar